Jenburkt Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 356.6 million compared to INR 345.66 million a year ago. Revenue was INR 370.05 million compared to INR 360.3 million a year ago. Net income was INR 54.04 million compared to INR 54.34 million a year ago. Basic earnings per share from continuing operations was INR 12.25 compared to INR 11.84 a year ago.
For the nine months, sales was INR 1,031.25 million compared to INR 1,015.5 million a year ago. Revenue was INR 1,066.03 million compared to INR 1,054.18 million a year ago. Net income was INR 180.95 million compared to INR 182.53 million a year ago. Basic earnings per share from continuing operations was INR 41 compared to INR 39.77 a year ago.